Phyton Biotech recognized as a 2025 Life Sciences BC Company to Watch
Life Sciences BC announced that Phyton Biotech was included in its list of 2025 LSBC Companies to Watch as part of its 27th Annual Life Sciences BC Awards. This recognition highlights outstanding companies to take note of and watch in the life sciences and biotech sectors.
Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way
Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.
Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada
Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development.
Phyton Biotech to attend BIO-Europe 2023
Phyton Biotech is delighted to be attending BIO-Europe in Munich from November 6th to 8th, 2023.
Phyton Biotech to attend CPhI Worldwide in Barcelona
Phyton Biotech to attend CPhI Europe in Barcelona from October 24-26, 2023
Phyton Biotech to participate in BioJapan
Phyton Biotech to attend BioJapan from October 11 to 13, 2023